The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Dr. Gabor Balazsi, a Henry Laufer Professor of Physical and Quantitative Biology in the Laufer Center at Stony Brook ...

DGIST Department of New Biology Professor Yea Kyungmoo and his research team have developed a next-generation exosome-based ...

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...

The Fremont, California-based contract development and manufacturing organization is planning another facility north of Houston.

Scientists are working hard on ways to minimize radiation therapy’s side effects on patients. A joint project of the ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Hanwha, which bought the South Philly yard last year, wants to add waterfront land and may expand into South Jersey.